Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord blood platelet gel for hand skin ulcers due to chronic cutaneous GVHD
IRCT20141007019432N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of cord blood platelet gel in Chronic cutaneous graft-versus-host disease (cGVHD) and Cutaneous ulcer (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Effectiveness of cord blood platelet gel on GVHD wound treatment. Started Mar 2018; status: completed.
02
Drugs
cord blood platelet gel
03
Conditions
Chronic cutaneous graft-versus-host disease (cGVHD)Cutaneous ulcer
Beyond the preview
Go deeper on IRCT20141007019432N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141007019432N6.